INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Intra-Cellular Therapies, Inc.
Goldberg Law PC announces that it is investigating Intra-Cellular Therapies, Inc. (“Intra-Cellular Therapies” or
the “Company”) (Nasdaq: ITCI) concerning possible violations of federal securities laws.
If you purchased or otherwise acquired Intra-Cellular Therapies shares and would like more information regarding the
investigation, we encourage you to contact Michael Goldberg or
Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100,
Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s
website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.
The investigation concerns whether Intra-Cellular Therapies and certain of its officers and/or directors violated federal
securities laws. On August 4, 2016, the Company’s CEO Sharon Mates touted the “efficacy and safety of ITI-007 for the
treatment of schizophrenia.” On May 1, 2017, Intra-Cellular Therapies disclosed that the U.S. Food & Drug Administration
requested information from the Company in order to verify whether or not there are safety risks associated with long term exposure
of ITI-007 to patients. When this news was announced, Intra-Cellular Therapies’ stock price dropped sharply.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170502006357/en/